Whalegun
Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 02/13

Trade details

Type
Insider sale
Amount
$175,077.84
Shares · price
6,348 sh · $27.58 a share
Held after
44,089 sh
Stock
Mineralys Therapeutics MLYS
Person
David Malcom RodmanChief Medical Officer
Trade date
26/02/13
Filed
26/02/13
Days to filing
0 days

Sold 12.6% of holdings

Share of holding sold
12.6%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 01/14~03/15

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13